Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer

Bekric, D; Neureiter, D; Ablinger, C; Dobias, H; Beyreis, M; Ritter, M; Jakab, M; Bischof, J; Koller, U; Kiesslich, T; Mayr, C

Mayr, C (通讯作者),Paracelsus Med Univ, Inst Physiol & Pathophysiol, Ctr Physiol Pathophysiol & Biophys, A-5020 Salzburg, Austria.;Mayr, C (通讯作者),Paracelsus Med Univ, Univ Hosp Salzburg SALK, Dept Internal Med 1, A-5020 Salzburg, Austria.

CANCERS, 2023; 15 (5):